1. Individualized cumulative cisplatin dose for locoregionally-advanced nasopharyngeal carcinoma patients receiving induction chemotherapy and concurrent chemoradiotherapy. (August 2020) Authors: Wen, Dan-Wan; Li, Zhi-Xuan; Chen, Fo-Ping; Lin, Li; Peng, Bin-ying; Kou, Jia; Zheng, Wei-Hong; Yang, Xing-Li; Xu, Si-Si; Sun, Ying; Zhou, Guan-Qun Journal: Oral oncology Issue: Volume 107(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma. (February 2021) Authors: Liang, Shao-Bo; Chen, Lu-Si; Yang, Xing-Li; Chen, Dan-Ming; Wang, Dong-Hui; Cui, Chun-Yan; Xie, Chuan-Bo; Liu, Li-Zhi; Xu, Xiang-Ying Journal: Radiotherapy and oncology Issue: Volume 155(2021) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China. (April 2021) Authors: Wen, Dan-Wan; Lin, Li; Mao, Yan-Ping; Chen, Chun-Yan; Chen, Fo-Ping; Wu, Chen-Fei; Huang, Xiao-Dan; Li, Zhi-Xuan; Xu, Si-Si; Kou, Jia; Yang, Xing-Li; Ma, Jun; Sun, Ying; Zhou, Guan-Qun Journal: Radiotherapy and oncology Issue: Volume 157(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective study. (March 2021) Authors: Liang, Shao-Bo; Chen, Lu-Si; Chen, Hai-Yang; Yang, Xing-Li; Wang, Dong-Hui; Cui, Chun-Yan; Xie, Chuan-Bo; Liu, Li-Zhi; Xu, Xiang-Ying Journal: Radiotherapy and oncology Issue: Volume 156(2021) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. (March 2019) Authors: Liang, Shao-Bo; Zhang, Ning; Chen, Dan-Ming; Yang, Xing-Li; Chen, Bin-Hong; Zhao, Hai; Lu, Rui-Liang; Chen, Yong; Fu, Li-Wu Journal: Radiotherapy and oncology Issue: Volume 132(2019) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗